Mountain View, CA, United States of America

Brian DeChristopher

This inventor holds 1 USPTO granted patent. Top assignee: Leland Stanford Junior University. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Brian DeChristopher. Retrieved from https://idiyas.com/inventor/brian-dechristopher

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Brian DeChristopher: Innovator in Prostratin Analog Research

Introduction

Brian DeChristopher is a notable inventor based in Mountain View, CA (US). He has made significant contributions to the field of medicinal chemistry, particularly through his work on prostratin analogs and related compounds. His innovative research has the potential to impact therapeutic applications significantly.

Latest Patents

Brian DeChristopher holds a patent for "Prostratin analogs, bryostatin analogs, prodrugs, synthetic methods, and methods of use." This patent encompasses various embodiments that provide for prostratin analogs, bryostatin analogs, and prodrugs of these compounds. The methods outlined in the patent detail the synthesis of these analogs and their potential uses in medical applications.

Career Highlights

DeChristopher is affiliated with Leland Stanford Junior University, where he conducts his research. His work has been recognized for its innovative approach to developing new therapeutic agents. The focus on prostratin and bryostatin analogs highlights his commitment to advancing medicinal chemistry.

Collaborations

Some of his notable coworkers include Paul A. Wender and Lars V. Heumann. Their collaborative efforts contribute to the advancement of research in the field, fostering innovation and discovery.

Conclusion

Brian DeChristopher's work in the development of prostratin analogs represents a significant advancement in medicinal chemistry. His contributions are poised to influence future therapeutic strategies and enhance our understanding of these complex compounds.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…